Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
Clinical trial NCT01113515 · COMPLETED
Trial details
- NCT number
- NCT01113515
- Sponsor
- Novalead Pharma Private Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-20
- Primary completion
- 2015-06-27
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.